Artiva Biotherapeutics, Inc. layoffs
Yes. Artiva Biotherapeutics, Inc. has filed 2 SEC 8-Ks with Item 2.05 (exit or disposal costs) since 2023. The most recent, on Nov 9, 2026, disclosed a workforce reduction.
Check ARTV layoff riskSEC filings since 2023
- Nov 92026
Artiva Biotherapeutics discloses a workforce reduction
Artiva Biotherapeutics, Inc. (ARTV) · filed yesterdayOn October 27, 2026, Artiva Biotherapeutics, Inc.
- Oct 272026
Artiva Biotherapeutics discloses a workforce reduction
Artiva Biotherapeutics, Inc. (ARTV) · filed 2 weeks agoOn October 22, 2026, the board of directors of the Company approved the discontinuation of the Company’s development of AlloNK ® (AB-101), its non-genetically modified, allogeneic natural killer (NK) cell therapy candidate, as the Company conducts a process to explore strategic alternatives to maximize stockholder value, which includes a plan to implement a reduction of the Company’s workforce by approximately 94%…
Get this data via API
Pull layoff filings, risk scores, and WARN notices into your own product. Starts at $49/mo.